Article | November 3, 2021

Knowledge Is Power: Overcoming Common Bioprocess Development Challenges

Cell expansion iStock-1090837544

Efficient bioprocess development is a vital objective for all biopharmaceutical developers, particularly as product demand rises. Whether the product is a recombinant protein or a vaccine, effectively achieving this goal is essential to accelerate the product to market and enable economically sustainable large-scale manufacturing in the long term.

Decisions regarding the bioprocess cell line, media, scale-up, and regulatory approval can have direct effects on overall product speed to market and costs. Relatively minor mistakes during these stages can slow down regulatory approval and potentially lead to scale-up failures, which can cause additional delays and costs.

Given the importance of bioprocess development toward setting the pace of getting biopharmaceutical products to commercial launch, the need for this to be as successful and efficient as possible is clear. It is also clear that, regardless of whether process development is undertaken in-house or with an external collaborator, many potential challenges can arise during the process.

Fortunately, many of these inefficiencies and mistakes are due to well-known process development challenges which, once understood, can be mitigated or even avoided altogether. Gaining this knowledge and successfully addressing these challenges can reduce risk, dramatically increase the likelihood of successful process development, and accelerate the delivery of innovative new treatments to the patients who need them.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online